Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$126.46 - $235.05 $273,912 - $509,118
-2,166 Closed
0 $0
Q4 2021

Jan 31, 2022

SELL
$225.82 - $368.51 $3.19 Million - $5.21 Million
-14,131 Reduced 86.71%
2,166 $363,000
Q3 2021

Oct 19, 2021

BUY
$221.9 - $484.47 $80,327 - $175,378
362 Added 2.27%
16,297 $5.41 Million
Q2 2021

Jul 21, 2021

SELL
$129.91 - $234.98 $1.46 Million - $2.63 Million
-11,212 Reduced 41.3%
15,935 $3.75 Million
Q1 2021

Apr 14, 2021

BUY
$109.18 - $185.98 $126,867 - $216,108
1,162 Added 4.47%
27,147 $3.53 Million
Q4 2020

Jan 19, 2021

BUY
$65.74 - $169.86 $387,865 - $1 Million
5,900 Added 29.38%
25,985 $2.22 Million
Q3 2020

Oct 13, 2020

BUY
$54.34 - $94.85 $2,717 - $4,742
50 Added 0.25%
20,085 $1.45 Million
Q2 2020

Jul 13, 2020

BUY
$29.67 - $80.0 $594,438 - $1.6 Million
20,035 New
20,035 $1.22 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Dfpg Investments, LLC Portfolio

Follow Dfpg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dfpg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dfpg Investments, LLC with notifications on news.